tirzepatide surpass-4 trial: slows rate of eGFR decline and reduces UACR in T2DM patients Post Hoc Analysis of SURPASS-1
Pay in 4 interest-free payments of $5.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29


























